Selecting anti-HIV therapies based on a variety of genomic and clinical factors
- Michal Rosen-Zvi
- Andre Altmann
- et al.
- 2008
- Bioinformatics
Prof. Rosen-Zvi is the Director, AI for Drug Discovery at IBM Research and an adjunct Computational Medicine Professor at the Hebrew University at the Faculty of Medicine. She is also heading the AI for accelerated HC&LS discovery department at IBM Research, Israel. Michal holds a PhD in computational physics and completed her postdoctoral studies at UC Berkeley, UC Irvine, and the Hebrew University in the area of Machine Learning. She joined IBM Research in 2005 and has since led various projects in the area of machine learning and healthcare and was recognized for her contribution e.g. to AI technologies in wafer production and contributions to partnerships with pharmaceutical companies such as Guerbet and Teva. Michal has published more than 50 peer-reviewed papers that were cited more than 5500 times according to Google Scholar. She is a member of the iScience Editorial Advisory Board, a member of the Israeli National Council of Digital Health and Innovation and an elected member of the Board of the Israeli Society for HealthTech.